You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blastic Plasmacytoid Dendritic Cell Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Yerevan

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    Jul 4, 2022

    Patients Previously Treated WithMustang Bio CAR-T Cell

    Enrolling by invitation
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • +10 more
    • Prior MB-102 CAR-T cell investigational product.
    • Prior MB-106 CAR-T cell investigational product.
    • Duarte, California
    • +4 more
    Dec 8, 2022

    Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

    Recruiting
    • Leukemia, Acute Myeloid
    • +7 more
    • Denver, Colorado
    • +4 more
    Aug 29, 2022

    Acute Myeloid Leukemia Trial in Italy (tagraxofusp)

    Recruiting
    • Acute Myeloid Leukemia
    • Bergamo, Italy
    • +7 more
    Dec 17, 2021

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +16 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 1, 2022

    Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • XmAb14045
    • Jacksonville, Florida
    • +8 more
    Mar 4, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

    Active, not recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Tagraxofusp-erzs
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 8, 2022

    Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

    Not yet recruiting
    • Acute Leukemia of Ambiguous Lineage
    • +8 more
    • Biospecimen Collection
    • +12 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 22, 2023

    Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • +3 more
    • Gilbert, Arizona
    • +14 more
    Apr 20, 2022

    Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

    Recruiting
    • Acute Biphenotypic Leukemia
    • +11 more
    • Total-Body Irradiation
    • +8 more
    • Los Angeles, California
    • +9 more
    Aug 19, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • TregGraft (Orca-T)
    • Duarte, California
    • +13 more
    Oct 28, 2021

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in United States (MB-102, Fludarabine, Cyclophosphamide)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • MB-102
    • +2 more
    • Duarte, California
    • +3 more
    Jul 12, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Acute Myeloid Leukemia
    • Duarte, California
    • +8 more
    Apr 6, 2020

    Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Seoul, Gang Nam, Korea, Republic of
        Samsung medical center
      Sep 1, 2020

      Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

      Not yet recruiting
      • Refractory Leukemia
      • +4 more
      • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
      • Dendritic Cell Vaccine
      • Miami, Florida
        University of Miami
      Jan 23, 2023

      Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor, Unclassifiable

      Withdrawn
      • Acute Bilineal Leukemia
      • +11 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 12, 2020

      Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

      Recruiting
      • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 30, 2021

      Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

      Active, not recruiting
      • Aggressive Non-Hodgkin Lymphoma
      • +9 more
      • Cryosurgery
      • +5 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Aug 9, 2022

      Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

      Recruiting
      • Acute Myelogenous Leukemia
      • DC/AML Fusion Vaccine
      • Observation
      • Atlanta, Georgia
      • +4 more
      Apr 14, 2022

      Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

      Recruiting
      • Acute Myelogenous Leukemia
      • Boston, Massachusetts
      • +1 more
      Nov 15, 2021

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023